June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Radiation Therapy for Small Choroidal Melanoma: 10-years Experience with Palladium-103 Plaque Radiation Therapy
Author Affiliations & Notes
  • Kimberly Chin
    The New York Eye Cancer Center, New York, NY
  • Ekaterina Semenova
    The New York Eye Cancer Center, New York, NY
  • Paul Finger
    The New York Eye Cancer Center, New York, NY
  • Footnotes
    Commercial Relationships Kimberly Chin, None; Ekaterina Semenova, The Eye Cancer Foundation (F); Paul Finger, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4234. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kimberly Chin, Ekaterina Semenova, Paul Finger; Radiation Therapy for Small Choroidal Melanoma: 10-years Experience with Palladium-103 Plaque Radiation Therapy. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4234. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate outcomes (vision, local control, complications) after ophthalmic plaque radiation therapy for small choroidal melanomas.

Methods: Ninety one patients with small choroidal melanomas (<2.5 mm apical height and <10 mm wide) were treated with palladium-103 plaque brachytherapy between 2002-2012. Pre-operative tumor thickness ranged from 1.5 to 2.5 mm (mean 2.2 mm, CI 2.1-2.3 mm). Tumor base diameters ranged from 5.5 to 10.0 mm (mean 8.4 mm, CI 8.2-8.7). Thirty one patients (34.1%) in this study were observed for change from 2 months to 16 years prior to radiation treatment.

Results: Plaque radiotherapy provided local tumor control in 98.9% at a mean 55 months of observation (95% CI 48-62 months). One patient failed treatment. Mean tumor apex dose was 82.3Gy (range 70.0-102 Gy). The most common long-term brachytherapy-related complications were radiation retinopathy (47.3%) and radiation optic neuropathy (19.8%) developing 9 to 72 months after brachytherapy (mean 26 months). These complications were typically stabilized by periodic anti-VEGF intravitreal injections. In this series 85 patients (93.4%) maintained 20/200 or better vision. Metastasis developed in one patient (1.1%).

Conclusions: These findings support palladium-103 plaque radiotherapy as an effective method to treat small choroidal melanomas. While informed consent plays a critical role in small melanoma case selection, treated patients should expect excellent local control rates and better visual acuity outcomes compared to treatment of larger choroidal melanomas.

Keywords: 589 melanoma • 671 radiation therapy  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×